SCHEMBL24671856

SCHEMBL24671856

CCCCc1csc(N)c1C(=O)OCC

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.68
▸ SMN1; SMN2 Q16637 3/20 0.68
▸ MAPK1 P28482 3/20 0.68
▸ POLB P06746 1/20 0.68
▸ PRKCZ Q05513 9/20 0.55
▸ HSD17B10 Q99714 6/20 0.53
▸ HPGD P15428 3/20 0.53
▸ MAPT P10636 6/20 0.52
▸ KMT2A Q03164 6/20 0.52
▸ MEN1 O00255 5/20 0.52
▸ ALOX15 P16050 4/20 0.52
▸ GAA P10253 3/20 0.52
▸ MPI P34949 1/20 0.52
▸ USP2 O75604 1/20 0.52
▸ KEAP1 Q14145 1/20 0.52
▸ TDP1 Q9NUW8 2/20 0.51
▸ CASP1 P29466 1/20 0.51
▸ CASP7 P55210 1/20 0.51
▸ PRKCI P41743 2/20 0.50
▸ FHIT P49789 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10532585 0.87 ALDH1A1 (0.75) ALDH1A1SMN1; SMN2MAPK1POLBPRKCZ
SCHEMBL13369154 0.83 ALDH1A1 (0.69) ALDH1A1SMN1; SMN2MAPK1POLBPRKCZ
SCHEMBL4933891 0.82 ALDH1A1 (0.68) ALDH1A1SMN1; SMN2MAPK1POLBPRKCZ
SCHEMBL16663489 0.82 ALDH1A1 (0.68) ALDH1A1SMN1; SMN2MAPK1POLBPRKCZ
SCHEMBL5278960 0.81 GABRP (0.45) ALDH1A1SMN1; SMN2MAPK1POLBHSD17B10
SCHEMBL9097409 0.81 ALDH1A1 (1.00) ALDH1A1SMN1; SMN2MAPK1POLBPRKCZ
SCHEMBL13814898 0.79 ALDH1A1 (0.64) ALDH1A1SMN1; SMN2MAPK1POLBPRKCZ
SCHEMBL162443 0.79 ALDH1A1 (0.63) ALDH1A1SMN1; SMN2MAPK1POLBPRKCZ
SCHEMBL6031612 0.78 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2MAPK1POLBPRKCZ
SCHEMBL8907488 0.78 ALDH1A1 (0.61) ALDH1A1SMN1; SMN2MAPK1POLBPRKCZ

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220356164-A1 2-AMINOSELENOPHEN COMPOUNDS WITH ANTI-DRUG RESISTANT BACTERIA ACTIVITY AND A METHOD OF PREPARING THE SAME ZHUHAI JINAN SELENIUM SOURCE NANOTECHNOLOGY CO., LTD. (CN) 2022-11-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220356164-A1 2-AMINOSELENOPHEN COMPOUNDS WITH ANTI-DRUG RESISTANT BACTERIA ACTIVITY AND A METHOD OF PREPARING THE SAME SLC11A2, LSS, AASDHPPT ALDH1A1 2155/4885SMN1; SMN2 4340/4885MAPK1 2588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback